If youve been thinking about taking a GLP-1 or dual GIP/GLP-1 agonist, you likely have lots of questions
At worst, excessive topical use causes local irritation, which resolves when you reduce application
The absence of a control group precludes definitive conclusions on causality between GLP-1 receptor agonist therapy and observed outcomes, and residual confounding cannot be excluded In conclusion, arGLP-1 represent a valuable addition to the therapeutic arsenal for managing IWL or WR after BS
[PMID: 15171598] PubMed record related to this compound for laboratory literature review
Oxidized glutathione bound to arsenic (purple), a human carcinogen (Rubino, 2015)
So obviously what youve tried hasnt worked, so theyre trying something different. Your prep for the appointment is refreshingly simple, though